Cardiovascular and neuropsychiatric risks of varenicline: a retrospective cohort study

BACKGROUND: Varenicline is an effective pharmacotherapy to aid smoking cessation. However, its use is limited by continuing concerns about possible associated risks of serious adverse cardiovascular and neuropsychiatric events. The aim of this study was to investigate whether use of varenicline is a...

Descripción completa

Detalles Bibliográficos
Autores principales: Kotz, Daniel, Viechtbauer, Wolfgang, Simpson, Colin, van Schayck, Onno C P, West, Robert, Sheikh, Aziz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593936/
https://www.ncbi.nlm.nih.gov/pubmed/26355008
http://dx.doi.org/10.1016/S2213-2600(15)00320-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4593936/
https://www.ncbi.nlm.nih.gov/pubmed/26355008
http://dx.doi.org/10.1016/S2213-2600(15)00320-3

Ejemplares similares